ES2546866T3 - Polimorfos de darunavir - Google Patents

Polimorfos de darunavir Download PDF

Info

Publication number
ES2546866T3
ES2546866T3 ES09852224.6T ES09852224T ES2546866T3 ES 2546866 T3 ES2546866 T3 ES 2546866T3 ES 09852224 T ES09852224 T ES 09852224T ES 2546866 T3 ES2546866 T3 ES 2546866T3
Authority
ES
Spain
Prior art keywords
darunavir
polymorphs
solvate
alcohol
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09852224.6T
Other languages
English (en)
Inventor
Bandi Parthasaradhi Reddy
Kura Rathnakar Reddy
Dasari Muralidhara Reddy
Rapolu Raji Reddy
Kesireddy Subash Chander Reddy
Bandi Vamsi Krishan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hetero Research Foundation
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Application granted granted Critical
Publication of ES2546866T3 publication Critical patent/ES2546866T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Un solvato de alcohol C5 de darunavir.

Description

imagen1
imagen2
imagen3
imagen4

Claims (1)

  1. imagen1
ES09852224.6T 2009-12-16 2009-12-16 Polimorfos de darunavir Active ES2546866T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2009/000724 WO2011073993A1 (en) 2009-12-16 2009-12-16 Polymorphs of darunavir

Publications (1)

Publication Number Publication Date
ES2546866T3 true ES2546866T3 (es) 2015-09-29

Family

ID=44166823

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09852224.6T Active ES2546866T3 (es) 2009-12-16 2009-12-16 Polimorfos de darunavir

Country Status (7)

Country Link
US (3) US20110313035A1 (es)
EP (1) EP2513116B1 (es)
CN (1) CN102686594A (es)
CA (1) CA2784131C (es)
ES (1) ES2546866T3 (es)
PT (1) PT2513116E (es)
WO (1) WO2011073993A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
ES2546866T3 (es) 2009-12-16 2015-09-29 Hetero Research Foundation Polimorfos de darunavir
AU2010340799B2 (en) * 2010-01-05 2015-06-11 Cipla Limited Darunavir polymorph and process for preparation thereof
EP2528923B1 (en) 2010-01-28 2014-07-30 Mapi Pharma Limited Process for the preparation of darunavir and darunavir intermediates
EP2571355B1 (en) 2010-05-20 2016-09-07 Hetero Research Foundation Crystalline hydrochloride salt of darunavir
WO2012107889A1 (en) * 2011-02-10 2012-08-16 Ranbaxy Laboratories Limited Process for the preparation of amorphous darunavir
WO2013108105A2 (en) 2012-01-18 2013-07-25 Aurobindo Pharma Limited Novel solvates of darunavir
CN103509031B (zh) * 2012-06-20 2016-04-27 上海迪赛诺药业有限公司 制备达芦那韦无定形物的方法
ES2848216T3 (es) 2012-07-24 2021-08-05 Laurus Labs Ltd Un proceso para la preparación de Darunavir
WO2016092525A1 (en) * 2014-12-12 2016-06-16 Lupin Limited Darunavir n-propanol solvate and process for preparation thereof
CN106854212A (zh) * 2015-12-08 2017-06-16 浙江九洲药业股份有限公司 一种达芦那韦无定型的制备方法
CN107235987A (zh) * 2016-03-28 2017-10-10 浙江九洲药业股份有限公司 一种地瑞那韦甲醇溶剂化物及其制备方法和用途
US10407438B2 (en) 2016-10-27 2019-09-10 Gilead Sciences, Inc. Crystalline forms of darunavir
CN108794498A (zh) * 2017-05-03 2018-11-13 江苏瑞科医药科技有限公司 一种达芦那韦无定型的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7310889A (es) 1972-08-12 1974-02-14
US4670578A (en) * 1983-08-29 1987-06-02 Merck & Co., Inc. Process for crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters
US4692438A (en) * 1984-08-24 1987-09-08 Hoffmann-La Roche Inc. Pyridazo-diazepines, diazocines, and -triazepines having anti-hypertensive activity
US5968942A (en) 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US5315016A (en) * 1992-10-13 1994-05-24 Nycomed Dak A/S Process for preparing pure podophyllotoxin
AU7669794A (en) 1993-08-24 1995-03-21 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
JP4776775B2 (ja) 1998-06-23 2011-09-21 アメリカ合衆国 Ｈｉｖ感染哺乳動物を治療するための医薬組成物
US20030125336A1 (en) 2001-05-30 2003-07-03 Fleitz Fred J. Hydrohalide salts of an HIV protease inhibitor
ES2503551T5 (es) * 2002-05-16 2021-10-28 Janssen Sciences Ireland Unlimited Co Formas pseudopolimórficas de un inhibidor de la proteasa de VIH
AU2003251627A1 (en) * 2002-06-27 2004-01-19 Sb Pharmco Puerto Rico Inc. Carvedilol hydrobromide
AU2005310490B2 (en) * 2004-12-02 2012-01-19 Daiichi Sankyo Company, Limited 7-membered ring compound, process for producing the same, and medicinal use thereof
WO2006067795A2 (en) * 2004-12-23 2006-06-29 Jubilant Organosys Limited Novel polymorphic forms of atorvastatin lactone and process for preparing the same
WO2007054969A2 (en) * 2005-09-21 2007-05-18 Torrent Pharmaceuticals Limited Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride
TWI385173B (zh) 2005-11-28 2013-02-11 Tibotec Pharm Ltd 作為ｈｉｖ蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物
ES2359949T3 (es) 2006-11-09 2011-05-30 Tibotec Pharmaceuticals Métodos para preparar hexhidrofuro(2,3-b)furan-3-ol.
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
US20120035142A1 (en) 2009-01-29 2012-02-09 Mapi Pharma Limited Polymorphs of darunavir
AU2010233718B2 (en) * 2009-04-09 2015-11-05 Sandoz Ag Crystal forms of Saxagliptin
ES2546866T3 (es) 2009-12-16 2015-09-29 Hetero Research Foundation Polimorfos de darunavir
EP2571355B1 (en) 2010-05-20 2016-09-07 Hetero Research Foundation Crystalline hydrochloride salt of darunavir

Also Published As

Publication number Publication date
EP2513116A1 (en) 2012-10-24
CN102686594A (zh) 2012-09-19
PT2513116E (pt) 2015-10-14
US20120288563A1 (en) 2012-11-15
US9580440B2 (en) 2017-02-28
US9624236B2 (en) 2017-04-18
CA2784131A1 (en) 2011-06-23
CA2784131C (en) 2017-07-11
EP2513116A4 (en) 2013-05-08
WO2011073993A1 (en) 2011-06-23
US20140200356A1 (en) 2014-07-17
EP2513116B1 (en) 2015-08-19
US20110313035A1 (en) 2011-12-22

Similar Documents

Publication Publication Date Title
ES2644844T3 (es) Mecanismo de soporte
ES2497167T5 (es) Una composición de bebida
ES2548578T3 (es) Monosebacato de un derivado de pirazol
ES2500067T3 (es) Compuesto bicíclico y uso del mismo para fines médicos
ES2448766T9 (es) Profármacos de dolutegravir
ES2642212T3 (es) Cierre de cremallera
EP2483770A4 (en) DYNAMIC IMAGE DISPLAY
ES2403197T5 (es) Instalación de lavado
BRPI0914239A2 (pt) método para produção de uma estrutura de parede anular
BRPI1010795A2 (pt) compostos antivirais
EP2262901A4 (en) PRIMARY ALCOHOL PRODUCING ORGANISMS
EP2350858A4 (en) DYNAMIC FRAGMENTATION OF DIGITAL MEDIA
CR20120295A (es) Triazolopiridinas
EP2098065A4 (en) SWARM PICTURE
BRPI0923797A2 (pt) Método para produzir um éster.
ES2642325T3 (es) Sonda de temperatura de núcleo
ES2642399T3 (es) Material cosmético emulsionado
DE602006019943D1 (de) Bilderzeugungsgerät
ES2644443T3 (es) Producción biotecnológica de condroitina
ES2485373T3 (es) Compuestos que actúan en múltiples receptores de prostaglandina proporcionando una respuesta anti-inflamatoria general
EA201070538A1 (ru) Улучшенный способ получения сложных диэфиров
ES2642085T3 (es) Procedimientos anaeróbicos de tratamiento de lodos
EP2627238A4 (en) SCANNER FOR AN ENDOSCOPE
DE602007013981D1 (de) Bilderzeugungsvorrichtung
DE602007011365D1 (de) Bilderzeugungsvorrichtung